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Abstract: Catharanthus roseus (L.) G. Don is a herbal plant traditionally used by local 
populations in India, South Africa, China and Malaysia to treat diabetes. The present study 
reports the in vitro antioxidant and antidiabetic activities of the major alkaloids isolated 
from Catharanthus roseus (L.) G. Don leaves extract. Four alkaloids—vindoline I, 
vindolidine II, vindolicine III and vindolinine IV—were isolated and identified from the 
dichloromethane extract (DE) of this plant’s leaves. DE and compounds I–III were not 
cytotoxic towards pancreatic β-TC6 cells at the highest dosage tested (25.0 µg/mL). All 
four alkaloids induced relatively high glucose uptake in pancreatic β-TC6 or myoblast 
C2C12 cells, with III showing the highest activity. In addition, compounds II–IV 
demonstrated good protein tyrosine phosphatase-1B (PTP-1B) inhibition activity, implying 
their therapeutic potential against type 2 diabetes. III showed the highest antioxidant 
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potential in ORAC and DPPH assays and it also alleviated H2O2-induced oxidative damage 
in β-TC6 cells at 12.5 µg/mL and 25.0 µg/mL. 
Keywords: Catharanthus roseus; alkaloids; β-TC6; C2C12; cytotoxicity; antioxidant; 
glucose uptake; PTP-1B 
 
1. Introduction 
Catharanthus roseus (L.) G. Don (Apocynaceae) is an ornamental shrub that grows up to  
30–100 cm in height. It was previously known as Vinca rosea (L.) and commonly known as 
Madagascar periwinkle. Although this plant originated from Madagascar, it is widely distributed around 
the World due to its high survivability in a variety of habitats and use as an ornamental plant [1]. This 
plant has a long history as a folk medicine in many countries [2] such as South Africa, China, India, 
Mexico [3] and Malaysia [4], where it is utilized as a remedy to alleviate diabetes complications [5].  
In Malaysia, the prevalence of known and newly diagnosed diabetes among adults of ≥30 years old 
showed an 80% rise from 8.3% in 1996 to 14.9% in 2006. In fact, Malaysia has already reached the 
projected prevalence for the year 2025. A survey by the Ministry of Health, Malaysia showed that 
majority of the diabetes patients were on oral medication (77%) and only a small percentage on insulin 
alone or in combination (7.2%). Apart from the standard treatment, some patients combined prescribed 
medications with alternative treatment, such as the use of local herbs, Chinese or Ayurvedic medicine. 
For example, some diabetes patients in Malaysia were reported to consume decoctions of this plant 
with improved health outcomes [6,7].  
Most reports on antidiabetic activity of this plant have been conducted using crude extracts [8–11] 
rather than the pure bioactive compounds. Chattopadhyay and Singh et al. showed that the extract of 
this plant exhibited hypoglycemic activity in a streptozotocin induced diabetic rat model [12,13].  
Ferreres et al. reported the scavenging ability for the aqueous leaves extract of this plant against DPPH 
(IC50 at 447 μg/mL), superoxide and nitric oxide radicals. Zheng et al. have showed the extract of this 
plant has the highest ORAC antioxidant capacity out of several medicinal herbs screened, with ORAC 
values of 22.30 μmol Trolox equivalent (TE)/g of fresh weight. The antioxidant activity of this plant 
was usually accessed along with their phenolic content as it exhibited high linear correlation with 
activity [14,15]. The antioxidant potential of alkaloids isolated from this plant has never been reported. 
Our preliminary study has found that the dichloromethane leaves extract (DE) of Catharanthus 
roseus (L.) G. Don exhibited antidiabetic activity, with enhanced glucose uptake in pancreatic (β-TC6) 
and myoblast (C2C12) cells. Thus, the aim of this study is to provide scientific evidence by examining 
the hypoglycemic and antioxidant activity of alkaloids isolated from the active extract of this plant 
using biochemical and in vitro assays. Firstly, we evaluated the antioxidant potential of the isolated 
alkaloids using oxygen radical absorbance capacity (ORAC) and 1,1-diphenyl-2-picrylhydrazyl 
(DPPH) radical scavenging assays. Secondly, we determined the cell viability, glucose uptake and 
H2O2-induced intracellular reactive oxygen species (ROS) generation, followed by the evaluation of 
the PTP-1B inhibitory effects of the isolated alkaloids. 
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2. Results and Discussion 
2.1. Results 
2.1.1. Identification of the Alkaloid Constituents 
The study on the alkaloids of Catharanthus roseus (L.) G. Don through DE yielded four known 
indole alkaloids, namely vindoline I, vindolidine II, vindolicine III, and vindolinine IV (Figure 1). 
The structures of these known alkaloids were established by comparing their 1H, 13C-NMR, and mass 
spectral data with literature values [16–19]. The structures were further confirmed through evaluation 
of the 2D-NMR spectra; HSQC, HMBC and COSY.  
Figure 1. Chemical structures alkaloids I–IV isolated from leaves of Catharanthus roseus. 
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2.1.2. Effect of Alkaloids on β-TC6 Cell Viability 
The alkaloids were evaluated for cytotoxic activity on β-TC6 cells (Table 1). The cells were treated 
for 24 h with various concentrations of DE or alkaloids I–IV. Cell viability was determined by MTT 
assays. IC50 of DE and compounds I–III exceeded 50 µg/mL, while, compound IV showed the most 
potent inhibition, with an IC50 of 20.5 ± 3.6 µg/mL (Table 1). On the other hand, doxorubicin, the 
standard anticancer drug exhibited IC50 at 3.8 ± 1.7 µg/mL. The present study demonstrated for the 
first time that DE and compounds I–III are safe at high dosage, while IV showed a moderate cytotoxic 
effect. However, it must be noted that all alkaloids I–IV were at least five fold less toxic towards  
β-TC6 cells compared to doxorubicin. 
Table 1. β-TC6 cell viability under treatment of DE and alkaloids I–IV. 
Cytotoxicity (IC50) DE Vindoline Vindolidine Vindolicine  Vindolinine 
µg/mL 78.4 ± 12.2 82.1 ± 9.8 76.7 ± 8.1 68.0 ± 10.4 20.5 ± 3.6 
µM - 180.1 ± 21.5 180.1 ± 19.0 73.5 ± 11.3 57.6 ± 10.7 
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2.1.3. ORAC Evaluation 
The ORAC results were expressed as Trolox equivalent (TE). Net areas under the fluorescein decay 
curve (AUC) with increasing dosage of Trolox demonstrated a linearity correlation with R2 value 
0.9668. Quercetin, the positive control demonstrated highest TE value at 406.5 ± 2.1 µM. Of all the 
isolated pure alkaloids, III (185.5 ± 4.9 µM) demonstrated the highest antioxidant property followed 
by II (92.0 ± 11.3 µM), IV (61.0 ± 19.8 µM) and I (41.0 ± 12.7 µM). DE also demonstrated relatively 
satisfactory activity at 66.5 ± 12.0 µM (Figure 2). 
Figure 2. ORAC activity of DE and alkaloids I–IV isolated from the leaves of 
Catharanthus roseus. Quercetin is included as positive control.  
 
2.1.4. DPPH Assay 
DPPH inhibitory activity of the four alkaloids were evaluated and compared to ascorbic acid,  
as the positive control (Figure 3). Compound III exhibited the strongest DPPH inhibition activity  
(52.9 ± 12.0 μM), followed by I (73.0 ± 14.7 μM), II (91.1 ± 20.9 μM), and IV (165.5 ± 53.0 μM). 
Compounds I–III showed better DPPH radical scavenging ability than ascorbic acid.  
Figure 3. DPPH inhibition activity of alkaloids I–IV. Ascorbic acid is included as positive control. 
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2.1.5. Effect of Alkaloids on H2O2-induced ROS Production in β-TC6 Cells 
High ROS can cause oxidative stress in cells and antioxidants are important in controlling damage 
caused by ROS production. Next, we evaluate the efficacy of these alkaloids in reducing H2O2-induced 
oxidative stress by monitoring 5-(and-6)-chloromethyl-2',7'-dichlorodihydrofluorescein diacetate  
(CM-DCFDA) fluorescence. H2O2 treatment alone resulted in higher signal compared to control 
(Figure 4). Pre-treatment with all four alkaloids significantly decreased the oxidant burden in a  
dose-dependent manner (* p < 0.05; Figure 4). Among the four alkaloids, III showed the highest 
antioxidant protective effect, followed by II, I and IV in that order (Figure 4). 
Figure 4. Intracellular H2O2-induced ROS production in β-TC6 cells pre-treated with 
alkaloids I–IV (* p < 0.05).  
 
2.1.6. Effect of Alkaloid on Glucose Uptake in β-TC6 and C2C12 Cells 
Improving glucose uptake in pancreatic or muscle cells could improve hyperglycemia condition of 
type 2 diabetes. DE dose-dependently increased glucose uptake, albeit the activity was relatively lower 
compare to the positive control, insulin (Figure 5A,B). Among the 4 pure alkaloids (I–IV) isolated,  
III stimulated the highest glucose uptake in β-TC6 and C2C12 cells with more than 3 fold enhancement 
in glucose uptake compared to untreated control (Figure 5A,B). Glucose clearance rates in I, II,  
and IV treated β-TC6 and C2C12 cells were significantly higher after treatment (Figure 5A,B).  
The fluorescent glucose 2-[N-(7-nitrobenz-2-oxa-1,3-diaxol-4-yl)amino]-2-deoxyglucose (2-NBDG) 
could be visualized around cytosol in β-TC6 and C2C12 cells treated with DE and the alkaloid I–IV 
(Figure 5C,D). 
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Figure 5. (A, B) Bar chart showing fluorescent intensity of 2-NBDG taken up by β-TC6 
and C2C12 myoblast cells. Insulin was included as positive controls. (* p < 0.05) (C, D) 
Representative photos showing enhanced glucose uptake by β-TC6 and C2C12 after 
treated with 25 µg/mL of alkaloids I–IV. Blue:Hoechst, Green: 2-NBDG. 
 
(A) 
 
(B) 
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Figure 5. Cont. 
(C) (D) 
2.1.7. Effect of Alkaloid on PTP-1B Inhibition 
The development of novel pharmaceutical agents that help ameliorate insulin resistance will be 
potentially important for the prevention and treatment of diabetes. PTP-1B is an enzyme that belongs 
to the protein tyrosine phosphatase family and a negative regulator of the insulin signaling pathway. 
To further evaluate antidiabetic potential of these compounds, we performed in vitro PTP-1B 
inhibition assays to determine whether DE or the isolated alkaloids I–IV were active inhibitors of  
PTP-1B. Compound III showed the highest inhibition activity, followed by IV, II and I. However,  
the activity of III was relatively weaker as compared to the positive controls (R)-3-hexadecanoyl-5-
hydroxymethyltetronic acid (RK-682) and ursolic acid (Figure 6). 
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Figure 6. PTP-1B inhibition of isolated alkaloids I–IV compare against the positive 
control drugs RK-682 and ursolic acid. 
 
2.2. Discussion 
In our study, the DCM leaves extract (DE) of this plant exhibited antioxidant and hypoglycemic 
activity in β-TC6 mouse pancreatic cells. Moreover, DE treatment resulted in good glucose uptake in 
C2C12 myoblast. The chemical investigation of DE yielded four alkaloids: vindoline I (1.0%), 
vindolidine II (0.14%), vindolicine III (0.07%) and vindolinine IV (0.02%). Compound III indicated 
the highest antioxidant property, followed by II, in our ORAC and DPPH assays. All four alkaloids 
exhibited moderate free radical scavenging activities. However, the presence of secondary reactions 
including those associated with repair mechanism [20] or antioxidant-metal reactions in ORAC assay 
may result in the reduction of active concentration which leads to under-estimation of ORAC value [21]. 
DPPH˙ is a relatively more stable radical which could provide a proper evaluation of a compound’s 
antioxidant activity [22]. In this study, we found that DPPH inhibition activity of I–III were better 
than the standard, ascorbic acid, except for IV. Overall, all four alkaloids exhibited relatively good 
antioxidant potential, with III being the best, although there are some slight discrepancies in the 
activity trends based on ORAC and DPPH assays. 
This is the first report on hypoglycemic activity of II and III as Svoboda had previously reported 
slight and moderate in vivo hypoglycemic activity of I and IV, respectively [23]. All four alkaloids  
I–IV exhibited enhanced glucose uptake with dose dependent activity in β-TC6 and C2C12 cells. The 
lower dosage could provide antioxidant effect to β-TC6 cells, which promoted cellular activity, and led 
to an increased level of glucose uptake. Among the four alkaloids, III showed the greatest 
enhancement of glucose uptake in β-TC6 and C2C12 cells. At the lowest dosage (12.5 µg/mL), the 
degree of glucose uptake increased in the order of I, II, IV and III, correlating with its PTP-1B 
inhibition activity. PTP-1B is a negative regulator of the insulin signaling pathway in human and is 
considered a promising potential therapeutic target for treatment of type 2 diabetes. For example,  
PTP-1B knock-out mice showed hyper obesity and prone to the development of type-2 diabetes. Thus, 
in light of these evidences, we speculate that PTP-1B signaling could play a role in controlling cellular 
glucose uptake activity in both β-TC6 and C2C12 cells. 
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Type I diabetes develops through autoimmune destruction of islet β-cells, while dysregulation of 
insulin secretion from β-cells due to oxidative damage could lead to type 2 diabetes [24]. Islet β-cells 
are vulnerable to oxidative stress and have a poor DNA repair capacity against oxidative damage. 
Recent study showed that type 2 diabetic individuals exhibited imbalance of ROS generation and 
neutralization [25]. Oxidative stress by ROS plays a central role in the development of diabetic 
complication, insulin resistance and β-cells dysfunction [26]. In the present study, H2O2 was applied to 
induce OH˙ free radicals, one of the most reactive and destructive oxidants. Compound III showed the 
highest reduction of H2O2-induced ROS production in β-TC6 cells, followed by II, I and IV, 
indicating the potential of III in alleviating oxidative stress in pancreatic cells. 
The present findings indicated that compound III possessed the best antioxidant and hypoglycemic 
activity through evaluation of ORAC, DPPH, ROS production, glucose uptake and PTP-1B inhibition 
assay compared to the other three alkaloids. Thus, we speculate that III is more beneficial and useful, 
in comparison with I or II or IV, for amelioration of type 2 diabetes due to its high antioxidant and  
PTP-1B inhibition activities. This strongly gives evidence to the use of this plant as an effective 
treatment of diabetes in several parts of the world and III can be viewed as a lead compound for the 
development of antidiabetic therapeutics. 
3. Experimental 
3.1. Plant Material 
Catharanthus roseus (L.) G. Don. was cultivated at Jeli, Kelantan, Malaysia from November 2008 
under natural condition. The leaves were collected around May 2009 and dried at 40 °C. The specimen 
was authenticated by Mr. Teo Leong Eng, a botanist in the Faculty of Science, University of Malaya. 
A voucher specimen with Herbarium No. of KL 5763 was deposited at the Herbarium in Department 
of Chemistry, University of Malaya, Kuala Lumpur, Malaysia.  
3.2. Extraction and Fractionation 
Dried grounded leaves of this plant (1 kg) was macerated with n-hexane (hex, 10.0 L) for 3 days at 
room temperature and this process was repeated twice. After removal of solvent, the plant residue was 
first wetted with 25% ammonia for an hour, followed by soaking with dichloromethane (DCM). The 
DCM extract (DE) was obtained after filtered and dried under reduced pressure. DE (42.6 g) was 
subjected for acid-base extraction using 5% hydrochloric acid (HCl) and 25% ammonia solution to 
obtain 4.2 g of alkaloid crude (DA). 
DA was subjected to column chromatography (CC) with silica gel 60 (Merck, Darmstadt, Germany) 
using gradient elution from DCM (100%) and DCM-methanol (95:5, 90:10, 85:15, 80:20, 75:25, 
70:30, 65:35, 60:40, 55:45, 50:50, v/v). The column was later flushed using DCM-methanol (40:60, 
20:80, v/v) and methanol (100%). 1000 mL of each different solvent system were used for elution. The 
eluent was collected in fractions of 100 mL. The fractions with the same thin layered chromatography 
(TLC) profile were then combined. A total of 15 fractions were obtained (Fractions 1–15). 
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3.3. Isolation and Purification 
Fraction 3 was subjected to preparative TLC (PTLC) separation using hex-ethyl acetate-acetone 
(20:78:2, v/v/v) under ammonia vapour on TLC silica gel 60 F204 (Merck) to yield I (428.1 mg) and II 
(57.9 mg). Fraction 4 was applied to PTLC with hex-ethyl acetate-acetone (20:79:1, v/v/v) under 
ammonia vapour to yield III (31.0 mg). PTLC of fraction 6 using the same solvent system as applied 
on fraction 4 yielded IV (8.4 mg).  
3.4. Identification and Characterization of Alkaloids 
One-dimensional and two-dimensional of 1H and 13C-NMR experiments were carried out on JEOL 
ECA 400 FT-NMR. CDCl3 was used as the solvent. The chemical shifts were recorded with reference 
to CDCl3 (7.24 ppm). LC-MS identification was carried out on Shimadzu Liquid Chromatography 
Mass Spectrometry-Ion Trap-Time Of Flight system equipped with pump (LC-20AD), autosampler 
(SIL-20AC), column oven (CTO-20AC), PDA detector (SPD-M20A) and coupled to an ESI interface 
(Shimadzu, Kyoto, Japan). 5 µL of isolated compounds were injected and chromatographed on a 
Waters XBridge C18 2.5 mm (2.1 × 50 mm) column with the mobile phase of A (0.1% formic acid in 
water) and B (0.1% formic acid in methanol). The mobile phase was performed in a step gradient as 
follows: isocratic 10% B for two min, 10% B to 100% B over the next 25 min and isocratic at 100% B 
for 5 min. The system was re-equilibrated for 5 min before the next run. Eluent were monitored using 
diode array detector at 220 nm, 254 nm, 350 nm and 450 nm. ESI-MS was performed in the range 
100–2,000 in both the positive and negative mode. The temperature of the heat block and curved 
desolvation line (the inlet for the high vacuum region) were set to 200 °C and 250 °C, respectively. 
Nitrogen gas was used as nebulizer with the flow rate set at 1.5 L/min. The ESI source voltage was set 
at 4.5 kV for positive mode and −3.5 kV for the negative mode whereas the detector was maintained at 
1.7 kV. Shimadzu’s LCMS solution software was used for data analysis. 
3.5. Cell Culture 
Mouse β-TC6 pancreatic cell line and mouse myoblast (skeletal muscle) C2C12 cell line were 
purchased from American Type Culture Collection (ATCC, Manassas, VA, USA). β-TC6 was cultured 
in 15% fetal bovine serum (FBS) in Dulbecco’s Modified Eagle Medium (DMEM) [27]. C2C12 cells 
were maintained in DMEM supplemented with 10% FBS. The cultures were kept in a humidified 
incubator at 37 °C in 5% CO2 and the growth medium was changed every 3 days. 
3.6. Cellular Viability 
The cytotoxic effects of DE and alkaloids on β-TC6 cell growth was determined by an MTT  
assay [28,29]. Briefly, 1.5 × 104 cells were seeded into a 96-well plate and incubated at 37 °C in 5% 
CO2 for 24 h. The second day, the seeded cells were treated with alkaloids and DE. After another 24 h 
of incubation, MTT solution was added at 2 mg/mL and the plates were kept in incubator at 37 °C in 
5% CO2 for 1 h. Absorbance at 570 nm was measured by a Plate Chameleon V microplate reader 
(Hidex, Turku, Finland). The obtained values are expressed as a percentage of cell viability after 
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exposure to DE and alkaloids for 24 h. Cell viability was defined as the ratio (percentage) of the 
absorbance of treated cells to that of untreated ones. 
3.7. ORAC Assay 
The ORAC assay was carried out based on the previously described procedure with slight  
modifications [30,31]. In brief, the sample/blank (175 μL) was dissolved in phosphate buffer saline 
(PBS) at the concentration of 160 μg/mL at pH 7.4. The Trolox standard was prepared in serial 
dilutions starting from 75 mM. Standard 96-well black microplates was used for the assay, and 25 μL 
each of the samples (DE and alkaloids), standard (Trolox), blank (solvent/PBS), or positive control 
(quercetin) were added to the wells. Fluorescent sodium salt solution was added at 150 μL per well, 
followed by incubation at 37 °C for 45 min. The total volume of each well was made up to 200 μL by 
adding 2,20-azobis-(2-amidinopropane) dihydrochloride (AAPH) solution. Fluorescence value was 
recorded at 37 °C until it became 0 (excitation at 485 nm, emission at 535 nm) using a fluorescence 
spectrophotometer (Perkin-Elmer LS 55) equipped with an automatic thermostatic autocell-holder. 
Data were collected every 2 min for 2 h and the data analysis was subsequently done by calculating  
the differences of AUC between the blank and the sample. The resulted values are expressed as  
Trolox equivalents. 
3.8. DPPH Assay 
The scavenging activity of all 4 alkaloids on DPPH (1,1-diphenyl-2-picrylhydrazyl) was determined 
based on the reduction of purple DPPH to yellow coloured diphenylpicrylhydrazine [32]. Different 
concentrations of the alkaloids in ethanol (ranging from 10–600 μg/mL) were tested. Sample solution 
in different concentrations was added at 2.5 mL in each well. Next, 0.3 mM DPPH ethanol solution  
(1 mL) was added to produce the test solutions, while ethanol (1 mL) was added to produce the blank 
solutions. Another 1 mL of DPPH solution was mixed with ethanol (2.5 mL) to prepare the negative 
control. The solutions were kept in the dark at room temperature for 30 min to let them react. The 
measurement of absorbance and colour changes was done at the wavelength of 518 nm. The following 
equation was applied to convert the absorbance values into percentage antioxidant activity:  
% Inhibition = [(B − T)/B] × 100 
where B: absorption of blank sample; T: absorption of tested samples. The half maximal inhibitory 
concentration (IC50) and the kinetics of DPPH scavenging activity were determined. Ascorbic acid was 
used as positive control in this assay. 
3.9. Intracellular ROS Measurement 
The fluorescent probe, CM-DCFDA (Invitrogen, Carlsbad, CA, USA), was used to monitor the 
intracellular generation of reactive oxygen species (ROS) by H2O2, as previously described [33].  
In brief, β-TC6 cells were pretreated with compounds for 2 h. CM-DCFDA (20 μM) was added for 
additional 30 min. The medium was then replaced with fresh medium containing 250 μM H2O2 and the 
cells were incubated for another 20 min. The intracellular ROS were determined using a fluorescence 
Molecules 2013, 18 9781 
 
 
spectrophotometer at Excitation/Emission = 485 nm/530 nm (Synergy Neo, Bio-Tek, Winooski,  
VT, USA).  
3.10. 2-NBDG Glucose Uptake 
β-TC6 or C2C12 cells were seeded at a density of 1.5 × 104 cells/mL in 96-well plate and allowed 
to attach, spread, and proliferate to near confluence at 37 °C in 5% CO2. After overnight incubation, 
the medium was discarded, washed with phosphate-buffered saline (PBS) twice and replenished with 
2.5 mM glucose in basal medium comprising DMEM without glucose or pyruvate supplemented with 
L-glutamine and 15% (v/v) FBS (final serum glucose concentration of approximately 0.25 mM).  
The cells were incubated for 60 min at 37 °C in 5% CO2. The conditioning medium was then replaced 
with 10 mM 2-NBDG (Invitrogen) in basal medium in the presence or absence of DE and  
alkaloids. The cells were kept at 37 °C in 5% CO2 for 30 min to permit endocytosis of the 2-NBDG. 
Then, the medium was removed, cells were washed twice with PBS and stained with nucleic dye 
Hoechst 33342 for another 30 min. The cells were then observed for intra-cellular fluorescence at  
Excitation/Emission = 350 nm/461 nm and Excitation/Emission = 475 nm/550 nm for Hoechst 33342 
and 2-NBDG, respectively. Plates were evaluated using the ArrayScan High Content Screening (HCS) 
system (Cellomics Inc., Pittsburgh, PA, USA) and analyzed with Target Activation BioApplication 
software (Cellomics Inc.) [34]. 
3.11. PTP-1B Inhibition 
para-Nitrophenyl phosphate (pNPP) was used as substrate to assay the phosphatase activity [35]. The 
ionic strength of the assay buffer (pH 7.4), was adjusted to 0.15 M using NaCl. The buffer contains  
50 mM 3,3-dimethylglutarate, 1 mM ethylenediaminetetraacetic acid (EDTA), 5 mM glutathione, and 
0.5% FCS (not heat inactivated). Briefly, diluted (50 μM alkaloids) and undiluted inhibitors were 
added to the reaction mixture containing 0 or 2.5 mM pNPP to reach the total volume of 100 μL. The 
enzyme (recombinant PTP-1B) was added to initiate the reaction. The reaction was allowed to proceed 
for 5 min before adding the inhibitor. The incubation was continued at 37 °C for 5–60 min and  
the time was recorded. Then 0.5 M NaOH in 50% ethanol (20 μL) was added to stop the reaction.  
To determine the enzyme activity, the absorbance was measured at 405 nm using a Tecan ELISA 
reader with appropriate corrections for absorbance of substrate, alkaloids, and nonenzymatic 
hydrolysis of substrate. 
3.12. Statistical Analysis 
Data were presented as means ± SEM (standard error of mean) and analyzed with unpaired 
Student’s t-test. p < 0.05 is considered significant. 
4. Conclusions  
In conclusion, all four alkaloids induced relatively high glucose uptake in β-TC6 and C2C12 cells. 
At low dosages, these alkaloids showed good antioxidant potential by alleviating H2O2-induced 
oxidative damage in β-TC6 cells. All four alkaloids; I–IV were less cytotoxic than the standard 
Molecules 2013, 18 9782 
 
 
anticancer drug doxorubicin towards β-TC6 cells. Among the alkaloids, III demonstrated the most 
potent activity in PTP-1B inhibition, which supports further development of III as a novel PTP-1B 
inhibitor that may serve as “insulin sensitizer” in the management of type 2 diabetes. 
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